Economic burden of varicella in Bangkok, Thailand: A multicenter medical chart review study

dc.contributor.authorSamant S.
dc.contributor.authorPawaskar M.
dc.contributor.authorChaisavaneeyakorn S.
dc.contributor.authorKamolratanakul S.
dc.contributor.authorLimpadanai S.
dc.contributor.authorJackson B.
dc.contributor.authorStephens J.
dc.contributor.authorSukarom I.
dc.contributor.authorChokephaibulkit K.
dc.contributor.correspondenceSamant S.
dc.contributor.otherMahidol University
dc.date.accessioned2024-06-28T18:11:36Z
dc.date.available2024-06-28T18:11:36Z
dc.date.issued2024-06-01
dc.description.abstractOur multicenter, medical chart review, cost-of-illness study used a micro-costing approach to evaluate the economic burden associated with varicella in Bangkok, Thailand, from a societal perspective. We reviewed medical charts of adults and children with a primary diagnosis of varicella (2014-2018) from 4 hospitals in Bangkok. Reported healthcare resource utilization and missed school or workdays were extracted from medical charts. Mean direct, indirect, and total costs per patient were estimated for overall, adult, and pediatric patients (2020 USD). Of the 200 children and 60 adults, 99.6%, 5.4%, and 5.4% had a varicella-related outpatient visit, emergency department visit, and hospitalization, respectively. The mean direct medical cost was 33 USD for pediatric and adult patients. The mean cost of outpatient visits (8 vs 13 USD, P<0.001) and medications (7 vs 9 USD, P<0.001) was significantly lower among pediatric patients. Forty-eight children reported a mean of 5.8 school days lost, and 32 adult patients reported a mean of 7.4 workdays lost. The mean total cost per varicella patient was 89 USD, with the mean total cost higher for adult than pediatric patients (145 vs 72 USD, P<0.001). Indirect cost accounted for 63% of the total cost per patient (54% for pediatric patients and 77% for adult patients). There is a substantial economic burden associated with patients seeking varicella-related healthcare in Thailand, including considerable indirect costs.
dc.identifier.citationPLOS Global Public Health Vol.4 No.6 (2024)
dc.identifier.doi10.1371/journal.pgph.0003099
dc.identifier.eissn27673375
dc.identifier.scopus2-s2.0-85196215692
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/99178
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleEconomic burden of varicella in Bangkok, Thailand: A multicenter medical chart review study
dc.typeArticle
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85196215692&origin=inward
oaire.citation.issue6
oaire.citation.titlePLOS Global Public Health
oaire.citation.volume4
oairecerif.author.affiliationRamathibodi Hospital
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationMahidol University
oairecerif.author.affiliationMerck &amp; Co., Inc.
oairecerif.author.affiliationMission Hospital
oairecerif.author.affiliationOPEN Health
oairecerif.author.affiliationMSD Thailand

Files

Collections